Benefit versus risk factors in prophylactic vaccination against rabies. 1979

M Bahmanyar

A reliable evaluation of the universally adopted post-exposure prophylactic treatment against rabies, initiated by Louis Pasteur, became feasible only sixty years after its world-wide application. Accumulated observations and data during that period revealed that vaccines currently used for that purpose were neither safe nor dependable in inducing protection against the invariably fatal disease. Thirty years of individual and internationally collaborative research has resulted in the discovery of a new type of vaccine and the adoption of a simple treatment procedure that is now confirmed to be both safe and practically with no failure in protection of man against rabies.

UI MeSH Term Description Entries
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

M Bahmanyar
January 1979, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Bahmanyar
May 2022, Iranian journal of public health,
M Bahmanyar
January 1979, Developments in biological standardization,
M Bahmanyar
June 1994, The Veterinary record,
M Bahmanyar
January 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene,
M Bahmanyar
April 1956, Polski tygodnik lekarski,
M Bahmanyar
June 1994, The Veterinary record,
M Bahmanyar
September 1950, Polski tygodnik lekarski,
M Bahmanyar
January 2008, Developments in biologicals,
M Bahmanyar
May 1969, Zeitschrift fur Allgemeinmedizin,
Copied contents to your clipboard!